AI-ECG Tracker vs eMurmur Heart AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Carewell Health
VS
by eMurmur

AI Verdict

Tool A, AI-ECG Tracker, specializes in the AI-powered analysis of 12-lead ECG electrical signals for a broad range of cardiac abnormalities, best suited for detailed cardiac diagnostics. In contrast, Tool B, eMurmur Heart AI, focuses on the automated analysis of heart and lung sounds to detect murmurs and provide hemodynamic insights, offering a complementary approach often used in screening and monitoring. Their distinct data inputs and diagnostic methodologies make them adjacent rather than direct competitors, serving different but related aspects of cardiac assessment.

Choose AI-ECG Tracker if…

Choose AI-ECG Tracker if your primary need is rapid, highly accurate, and comprehensive AI-powered auto-diagnosis of 12-lead ECG data for a wide range of cardiac abnormalities, including arrhythmias, myocardial ischemia, and infarction. This tool is ideal for clinical environments requiring powerful on-premise processing for detailed ECG interpretation and quick diagnostic support.

View AI-ECG Tracker →

Choose eMurmur Heart AI if…

Choose eMurmur Heart AI if you require an AI-powered platform for automated analysis of both heart and lung sounds, focusing on murmur detection, hemodynamic insights, and longitudinal monitoring. This solution is particularly well-suited for telehealth, remote consultation, and primary care settings where stethoscope-agnostic compatibility, mobile access, and live streaming auscultation are crucial for screening and tracking patient conditions.

View eMurmur Heart AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-ECG Tracker eMurmur Heart AI
Pricing Unknown Contact for quote
Deployment Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities. Web-based, Mobile App, API integration
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eMurmur Heart AI

Tool B offers a cloud-based, web application, and mobile app deployment with hardware-neutral and stethoscope-agnostic compatibility, providing greater flexibility and accessibility. In contrast, Tool A relies on an on-premise workstation and Windows client, which suggests a more involved setup and potentially less immediate user access.

Clinical Value

Tie

Both tools are FDA-cleared and provide significant clinical value in their respective specialized areas. Tool A offers highly accurate and rapid AI-powered ECG auto-analysis for a comprehensive range of 104 cardiac classifications. Tool B provides automated analysis of heart and lung sounds, detecting murmurs and offering hemodynamic insights, which is valuable for screening and remote monitoring. Their distinct diagnostic modalities make a direct comparison of superior clinical value challenging without a specific clinical context.

Pricing & Value

Tie

Neither Tool A nor Tool B provides publicly available pricing information. This lack of transparency makes it impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

eMurmur Heart AI

Tool B explicitly states HIPAA compliance and has a Business Associate Agreement (BAA), alongside a cloud-based architecture that typically offers greater scalability and easier integration for large healthcare systems. While Tool A offers an on-premise option and is 'likely' HIPAA compliant, Tool B's explicit compliance and cloud-native design provide a clearer and often preferred path for enterprise adoption.

Innovation

eMurmur Heart AI

Tool B demonstrates broader innovation by combining AI-powered analysis of both heart and lung sounds, providing hemodynamic insights, and enabling hardware-neutral, stethoscope-agnostic remote auscultation for telehealth. While Tool A is innovative in the depth and speed of its ECG analysis, Tool B's approach democratizes and enhances a traditionally subjective diagnostic method across a wider range of clinical settings.

Support & Docs

Tie

Both tools offer some form of documentation and contact information; Tool A mentions an 'Operator Manual' and a 'Help Center', and Tool B provides teaching apps and implied technical guidance. However, without specific details on the comprehensive nature, quality, or accessibility of their customer support channels (e.g., 24/7 availability, dedicated portals, SLAs), a definitive winner cannot be determined.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-ECG Tracker eMurmur Heart AI
Company Shenzhen Carewell Electronics Co. CSD Labs
Tagline Forever Innovation Forever Care! Auscultation AI for healthier hearts & lungs.
Primary Function AI-powered ECG auto-analysis and diagnosis Automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights
Key Differentiator (AI Focus) High accuracy (over 95%) for common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction; Rapid diagnosis in approximately 3 seconds Detection and classification of pathologic and innocent heart murmurs; Hemodynamic insights (loudness ratios of S1, systole, S2, diastole)
Supported Data Types 12-lead ECG data Heart and lung sounds (S1, S2, murmurs, crackles, wheezes)

Videos

Demos, reviews, and walkthroughs featuring AI-ECG Tracker and eMurmur Heart AI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AI-ECG Tracker focuses on AI-powered auto-analysis and diagnosis of 12-lead ECG data for common cardiac abnormalities like arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. eMurmur Heart AI specializes in automated analysis of heart and lung sounds to detect and classify murmurs and provide hemodynamic insights.
AI-ECG Tracker requires 12-lead ECG data collection for its analysis. In contrast, eMurmur Heart AI analyzes heart and lung sound data, compatible with various digital stethoscopes.
AI-ECG Tracker offers comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications, with over 95% accuracy for common cardiac abnormalities. eMurmur Heart AI detects and classifies pathologic and innocent heart murmurs, analyzes S1 and S2 heart sounds, and provides hemodynamic insights such as loudness ratios.
AI-ECG Tracker offers an optional cloud service for remote diagnostic services, allowing for remote review and management. eMurmur Heart AI explicitly supports live streaming and remote auscultation for telehealth, along with secure storage and playback of auscultation data.
AI-ECG Tracker is designed for Cardiology and Emergency Medicine. eMurmur Heart AI targets Cardiology, Internal Medicine, and Pulmonology.
AI Tool Finder
AI-powered search. Results may not be comprehensive.